MediFind
Condition

Epilepsy with Myoclonic-Atonic Seizures

Latest Research

Latest Advance
Study
  • Condition: COVID-19 in persons with epilepsy (Coronavirus)
  • Journal: Epilepsy research
  • Treatment Used: Chloroquine or hydroxychloroquine therapy
  • Number of Patients: 746
  • Published —
The study researched the use of chloroquine or hydroxychloroquine therapy for treating COVID-19 in persons with epilepsy (Coronavirus).
Latest Advance
Study
  • Condition: Lennox-Gastaut Syndrome and Dravet Syndrome
  • Journal: Epilepsia
  • Treatment Used: Cannabidiol Effectiveness Relative to Concomitant Clobazam
  • Number of Patients: 714
  • Published —
The purpose of the study was to evaluate the potential impact of concomitant clobazam use on the effectiveness of cannabidiol treatment in patients with Dravet syndrome and Lennox-Gastaut syndrome.
Latest Advance
Study
  • Condition: Neonatal Seizures
  • Journal: Pediatrics
  • Treatment Used: Levetiracetam or Phenobarbital
  • Number of Patients: 30
  • Published —
This study compared the clinical outcome of using levetiracetam or phenobarbital to treat patients with neonatal seizures.
Latest Advance
Study
  • Condition: Nonepileptic Myoclonus in Angelman Syndrome
  • Journal: Brain & development
  • Treatment Used: Perampanel
  • Number of Patients: 4
  • Published —
This study tested the effectiveness of perampanel for nonepileptic myoclonus in patients with Angelman syndrome.
Latest Advance
Study
  • Condition: Convulsive Seizure Frequency in Dravet Syndrome
  • Journal: JAMA neurology
  • Treatment Used: Adjunctive Oral Cannabidiol vs Placebo
  • Number of Patients: 199
  • Published —
This study evaluated the safety and effectiveness of a pharmaceutical formulation of cannabidiol, 10 and 20 mg/kg/d, versus placebo for adjunctive treatment of convulsive seizures in patients with Dravet syndrome.
Latest Advance
Study
  • Condition: Dravet Syndrome
  • Journal: CNS drugs
  • Treatment Used: Cannabidiol (CBD)
  • Number of Patients: 359
  • Published —
In this review of the literature, researchers evaluated the effects of cannabidiol (CBD) on the seizures of persons with Dravet syndrome.
Latest Advance
Study
  • Condition: Pediatric Epilepsy
  • Journal: Neurology
  • Treatment Used: Surgery
  • Number of Patients: 0
  • Published —
The study researched the outcomes of surgery for pediatric epilepsy.
Latest Advance
Study
  • Condition: Young Children with Drug-Resistant Epilepsy
  • Journal: Seizure
  • Treatment Used: Perampanel
  • Number of Patients: 38
  • Published —
This study described experience with perampanel in children under 7 years old with refractory epilepsy.
Latest Advance
Study
  • Condition: Seizures in Dravet Syndrome
  • Journal: Lancet (London, England)
  • Treatment Used: Fenfluramine Hydrochloride
  • Number of Patients: 119
  • Published —
The aim of the study was to assess the effectiveness and safety of fenfluramine in patients with Dravet syndrome.
Latest Advance
Study
  • Condition: Epilepsy
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Intravenous Immunoglobulins (IVIg)
  • Number of Patients: 61
  • Published —
This study examined the effects of intravenous immunoglobulin (IVIg) on the frequency and duration of seizures, quality of life, and adverse effects when used as monotherapy or as add-on treatment for people with epilepsy.
Latest Advance
Study
  • Condition: Congenital Generalized Lipodystrophy (CGL) with Progressive Myoclonic Epilepsy
  • Journal: Medicine
  • Treatment Used: Sodium Valproate, Baclofen, Aripiprazole, Benzhexol, Lamotrigine, and Nutrition Therapy
  • Number of Patients: 1
  • Published —
This case report discusses a child with congenital generalized lipodystrophy (CGL), a rare autosomal recessive hereditary disease, associated with metabolic complications and epilepsy, which is also rare.
Latest Advance
Study
  • Condition: Newly diagnosed epilepsy
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Clonazepam
  • Number of Patients: 115
  • Published —
This study assesses the efficacy and tolerability of oral Clonazepam used as monotherapy for newly diagnosed epilepsy, when compared with placebo or a different anti-seizure medication.